Sterol regulatory element-binding protein 2 (SREBP2), the master lipogenic regulator, directly upregulates the expression of the intracellular iron carrier transferrin (TF), which reduces the iron and LPO content to suppress ferroptosis and enhance the survival of circulating tumor cells (CTCs) and drug resistance (Hong et al., 2021). Here, TF is linked to neoplasm.